Argus recommends using the recent pullback in shares of Arcadium Lithium as a buying opportunity. The company’s lower earnings in Q1 were attributable to lower average realized prices for lithium, lower lithium volumes and higher operating costs, the analyst tells investors in a research note. The firm views the combination of Livent and Allkem as a strategic positive for both shareholder groups and believes that lithium will have a “long-lasting demand profile for years to come.” Argus expects the recent downtrend in lithium pricing to reverse course and slowly strengthen throughout 2024 and beyond. It keeps a Buy rating on Arcadium Lithium with a $6.25 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALTM:
- Arcadium Lithium initiated with an Outperform at RBC Capital
- Arcadium Lithium price target lowered to $3.75 from $5 at Piper Sandler
- Arcadium Lithium price target lowered to $5.50 from $6 at BMO Capital
- Regulatory Disclosure Risks: Arcadium Lithium Plc’s Challenge to Investor Confidence and Stability
- This Week in Lithium: China Limits Battery Capacity; Global Production Push Continues